Agreement Allows Astellas Pharma Inc. to Review Certain Confidential Information Related to OSI Pharmaceuticals, Inc.

MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that it had entered into an agreement with Astellas Pharma Inc., under which Astellas will be able to review certain confidential information related to OSI.

MORE ON THIS TOPIC